Clinical trial Recruiting at 1 site Observational Ages 18 and up

Gastric emptying and feeding tolerance in ICU patients by vasopressor dose

Official title: Point-of-Care Gastric Ultrasonography for Objective Assessment of Gastric Emptying Rate and Enteral Nutrition Tolerance According to Vasopressor Dose in Critically Ill Patients: A Prospective Observational Cohort Study

Run by Başakşehir Çam & Sakura City Hospital · NCT07802379 · Data updated 2026-11-12

This study tests whether vasopressor dose affects how well stomach contents empty during tube feeding in critically ill patients.

More Critical Illness trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment63 (estimated)
SponsorBaşakşehir Çam & Sakura City Hospital
Government
Locations1 site (Istanbul)
StatusRecruiting
StartedSeptember 2026
Main results expectedSeptember 2027
Study endsNovember 2027
Registry record updatedSeptember 3, 2026
Trial IDNCT07802379 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 or older in the ICU receiving nasogastric or orogastric feeding with at least 4 hours of uninterrupted enteral nutrition and meeting caloric targets.

Probably not a fit

Patients not on vasopressors or with very high hemodynamic instability where norepinephrine equivalents are not applicable may not derive information about vasopressor-related gastric emptying changes.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study analyzes the relationship between vasopressor dose and gastric emptying in ICU patients receiving enteral nutrition. Gastric emptying is measured by bedside ultrasound at baseline, 1 hour, and 2 hours after restarting feeding following a brief fast. Participants are grouped by norepinephrine equivalent dose to see if higher vasopressor exposure is associated with poorer gastric motility. The primary outcome is the gastric emptying rate, with gastroparesis defined as a gastric emptying rate of zero or less per hour. All ultrasounds are performed by a blinded ICU fellow to ensure objective assessments.

Why it matters

Potential benefit: If successful, the findings could help clinicians tailor enteral feeding strategies based on vasopressor use to reduce feeding intolerance and aspiration risk.

How similar studies have gone: Prior work supports the feasibility of noninvasive gastric ultrasound for assessing gastric emptying, but dose-dependent effects of vasopressors on GER are not well established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 years or older
* Admitted to the intensive care unit
* Receiving enteral nutrition via nasogastric or orogastric tube
* At least 4 hours of uninterrupted enteral nutrition prior to measurement
* At least 50% of daily caloric target achieved
* No change in feeding rate in the last 2 hours
* Written informed consent obtained from patient or legal representative

Exclusion Criteria:

* Age under 18 years
* History of gastrectomy or upper gastrointestinal surgery
* Known gastroparesis or diabetic gastropathy
* Active gastrointestinal bleeding
* Suspected bowel obstruction or perforation
* Prokinetic agent use within the last 24 hours
* BMI greater than 35 kg/m²
* Pregnancy
* Prone positioning more than 4 hours per day
* Intra-abdominal pressure greater than 15 mmHg
* Inadequate epigastric ultrasound window
* Jejunostomy, gastrostomy, or post-pyloric feeding tube
* Refusal of informed consent

Where it's running

  • Basaksehir Cam ve Sakura City Hospital
    Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.